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Background:  Depression  is common  in patients  with  cardiac  illness  and  is  independently  associated  with
elevated  morbidity  and mortality.  There  are  screening  guidelines  for depression  in  cardiac  patients,  but
the feasibility  and cost-effectiveness  of  screening  all  cardiac  patients  is controversial.  This  process  may  be
improved if a subset  of  cardiac  patients  at  high  risk  for depression  could  be identiﬁed  using information
readily  available  to clinicians  and  screened.
Objective:  To identify  risk  factors  for a  positive  depression  screen  at the  time  of admission  in  hospitalized
cardiac  patients.
Methods:  A  total  of  561  consecutively  screened  cardiac  inpatients  underwent  the  Patient  Health
Questionnaire-2  (PHQ-2).  A  prospective  chart  review  was  performed  to assess  potential  risk  factors  for
depression  that  would  be readily  available  to front-line  clinicians.  Rates  of  risk  factors  were  compared
between  patients  with  positive  and  negative  PHQ-2  depression  screens,  and multivariate  logistic  regres-
sion  was  performed  to assess  whether  speciﬁc  risk  factors  were  independently  associated  with  positive
screens.
Results:  Of  the 561  patients  screened,  13.5%  (n = 76) had  a positive  depression  screen  (PHQ-2  ≥  2).  In the
univariate  analyses,  several  variables  were  associated  with  a positive  depression  screen.  On  multivari-
9ate analysis,  an  elevated  white  blood  cell  (WBC)  count  (>10  ×10 cells  per liter)  and prescription  of an
antidepressant  on  admission  were  independently  associated  with  a positive  depression  screen,  while
current  smoking  showed  a trend  toward  signiﬁcance.
Conclusion:  Information  on  these  three  identiﬁed  risk  factors  (WBC  count,  antidepressant  use,  and  smok-
ing) is readily  available  to clinicians,  and  patients  with  these  diagnoses  may  represent  a  cohort  who
would  beneﬁt  from  targeted  depression  screening  in  certain  settings.
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Depression and heart disease are common conditions with
ajor public health signiﬁcance. Coronary artery disease is the
eading cause of death worldwide, causing more than 7 million
eaths per year [1].  Depression, another leading cause of global
isability [1], is common in patients with cardiac disease. Approx-
mately 15–20% of patients with cardiac disease, including those
ith congestive heart failure (CHF) [2,3] or acute coronary syn-
rome (ACS) [4,5] meet criteria for major depressive disorder
MDD). In these patients, depression has been independently asso-
iated with decreased health-related quality of life [6],  recurrent
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cardiac events and cardiac complications [7–9], increased rates of
hospitalization [10], and increased mortality at both short- and
long-term follow-up [10,11].
Given the effects of depression in cardiac patients, the American
Heart Association (AHA) has recommended systematic depres-
sion screening of cardiac patients using the Patient Health
Questionnaire-2 (PHQ-2) as an initial screen [12]. Although in some
circumstances systematic screening may  be feasible [13], the AHA
recommendations have been controversial given that depression
screening alone does not appear to improve medical outcomes in
primary care or cardiac patients [14] and that screening of large
numbers of patients may  not be practical in some settings. In situa-
tions where universal screening is impractical, it may  be desirable
to screen a subpopulation of cardiac patients at high risk for depres-
sion, using readily available clinical or demographic data.
Prior studies of risk factors for depression or positive depression
screens in cardiac patients have typically focused on a single or
small number of cardiac diseases and had relatively small sample
vier Ltd. All rights reserved.
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izes [15]. In addition, some information identiﬁed as ‘risk factors’
e.g. scores on research instruments) may  not be readily available
o clinicians in busy, real-world settings.
For selective depression screening to be feasible and effective,
t should utilize information that is readily available to clinicians,
ccur over a broad range of applicable diagnoses to provide an
conomy of scale, and be performed in patients for whom depres-
ion has a substantial impact. To our knowledge, prior studies in
ardiac patients have not examined risk factors for depression in
npatients at the time of hospital admission, assessed patients with
 wide range of cardiovascular illnesses, or screened a relatively
arge number of consecutively admitted cardiac patients.
To address this gap, we examined risk factors for a positive
epression screen in a consecutively-screened cohort of patients
dmitted with a wide range of cardiac diagnoses to one of the three
ardiac units at Massachusetts General Hospital.
ethods
verview
This was a prospective chart review of consecutive patients
dmitted to cardiac units at an urban academic medical center.
ll patients admitted to the units received a two-item depression
creen via the PHQ-2 as part of clinical care. Charts were sub-
equently reviewed to assess for sociodemographic and medical
haracteristics that may  have been associated with the presence
r absence of a positive PHQ-2. This study was approved by our
ealthcare system’s Institutional Review Board.
ubjects and depression screening
Subjects were patients who were admitted to one of three car-
iac inpatient units (one cardiac intensive care unit and two  cardiac
tep-down units) at an urban academic medical center between
pril 14, 2008 and June 9, 2008 with a primary cardiac diagno-
is, such as CHF, myocardial infarction (MI), unstable angina (UA),
rrhythmia, congenital heart disease, stent placement, pacemaker
lacement, or any other cardiac pathology that warranted hospital-
zation. Patients received depression screening from clinical cardiac
urses via the PHQ-2 during the initial nursing assessment as part
f clinical care. Nurses had been trained in person (and with writ-
en instructions) on the administration of the PHQ-2 depression
creening items at daytime and evening nursing staff meetings on
ultiple occasions. The PHQ-2 includes two items (to assess anhe-
onia and depressed mood for the prior two weeks) and its score
ange is 0–6 [16]. Patients with positive screens were evaluated for
ligibility for a prospective trial of depression management in car-
iac patients (www.clinicaltrials.gov, trial number NCT00847132).
e excluded patients for whom screening was not possible due to
ntubation, sedation, mental status changes, or due to poor English
anguage comprehension.
The PHQ-2 was selected as a screening tool because of its brevity,
asy implementation, validation and use in cardiac patients, and its
nclusion in the AHA recommendations [12,16]. For the purposes of
ligibility for the clinical trial, a PHQ-2 cutoff score of ≥3 was  used
o reduce the number of false positives. However, for this prospec-
ive chart review, the more standard PHQ-2 score cutoff of ≥2 as a
ositive depression screen was used; prior work in cardiac patients
ound this to be an optimal cutoff score, with a sensitivity of 82%
nd speciﬁcity of 79% for major depression [17]. In addition, com-
ared to a cutoff score of ≥3, a cutoff of ≥2 identiﬁes more potential
atients with depression, and given the relative ease of completing
 follow-up assessment for depression (e.g. with the PHQ-9), there
s not signiﬁcant concern about being overly inclusive.iology 60 (2012) 72–77 73
Chart review
For this prospective chart review, the medical records and PHQ-
2 screening results were recorded for patients admitted to the
units between April 14, 2008 and June 9, 2008 with a primary car-
diac diagnosis. For each admission, the subject’s electronic medical
record, including admission note, laboratory data, and discharge
summary were reviewed to assess for several demographic, psy-
chosocial, medical, and medication-related characteristics.
Although there may  be many characteristics associated with
a positive depression screen, we limited the variables we exam-
ined as potential risk factors. First, given that the goal was to
identify variables that could be used by front-line clinicians to
stratify depression risk, we required that each variable be readily
available to clinicians from prior records or the patient as part of
routine cardiac evaluation; any risk factor requiring inquiry about
additional factors (e.g. history of anxiety disorder) or additional
evaluation (e.g. data from research instruments such as social sup-
port scales) was not included. Second, we carefully selected the
variables based on prior literature on risk of depression in cardiac
and other medically-ill patients.
Based on these factors, we selected the following variables,
given their prior association with depression and cardiac illnesses:
• Demographic characteristics: gender, age, marital status, living
alone, and employment status [18–21].
• Medical historical characteristics: diabetes mellitus (DM), hyper-
tension (HTN), prior MI,  prior cerebrovascular accident (CVA),
history of coronary artery bypass graft (CABG), and medical hos-
pitalization within the past 6 months [7,8,10,18].
• Admission characteristics: admission diagnosis (MI  versus
admission for another cause), current smoking at admission,
white blood cell (WBC) count on admission, and use of anxiolytics,
antidepressants, or beta-blockers at admission [18,22–25].
Of these variables, we also, a priori, selected the subset of vari-
ables we  felt to be most likely to be associated with a positive
depression screen to be examined as part of an exploratory logis-
tic regression analysis as described below. This limitation of tested
variables was  done to reduce the number of variables in the sta-
tistical model and therefore decrease the risk of overﬁtting the
model.
Statistical analysis
Statistical analysis was performed using Stata version 11.0 (Stat-
aCorp LP, College Station, TX, USA). All statistical tests were two
tailed, with p < 0.05 deﬁned as statistical signiﬁcance.
Univariate analysis: Each of the clinical and demographic char-
acteristics above was analyzed to assess its association with a
positive depression screen as indicated by a PHQ-2 score of ≥2.
Between-group differences in these variables were compared using
chi-square analyses for categorical variables (e.g. DM)  and indepen-
dent samples t tests for continuous variables (e.g. WBC  count).
Multivariate analysis: To assess the independent association of
these variables with positive depression screens, we used logistic
regression analysis to create a multivariate model for the prediction
of positive depression screens indicated by a PHQ-2 score of ≥2. To
reduce overﬁtting in the regression model and otherwise optimize
analysis, we avoided preliminary ‘testing’ of variables via univari-
ate analysis, reduced the numbers of confounders tested, avoided
automatic stepwise regression techniques, and did not dichotomize
continuous variables [26]. For this analysis, we selected a priori
the variables that appeared to be most clearly associated with
risk of depression in prior studies [7,8,10,18–20,22–24],  namely
gender, age, marital status, living alone, history of DM,  admission
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iagnosis (MI  vs. other causes), tobacco use, hospitalization in the
rior 6 months, high WBC  count, use of anxiolytics, beta-blockers,
nd antidepressants.
Exploratory analyses. We  performed several exploratory analy-
es to better characterize the variables linked to positive depression
creens. First, we performed univariate analyses (using chi-square
nalysis and independent samples t tests as appropriate) of all vari-
bles using the more stringent PHQ-2 cutoff of ≥3; because of the
elatively small number of patients with a PHQ-2 score of 3 or
reater, we did not perform multivariate analysis using this cutoff
ue to the potential for overﬁtting [26].
Second, if any variables were independently associated with
 positive depression screen, we then calculated operating char-
cteristics [sensitivity, speciﬁcity, positive predictive value (PPV),
egative predictive value (NPV), and overall correct classiﬁcation
OCC)] for predicting positive depression screens for each individ-
al variable
Third, we then completed post hoc analyses by admission diag-
osis (e.g. UA) for any diagnostic group with over 100 subjects.
hese, again, would be univariate analyses assessing each of the
ariables’ association with a positive depression screen, but would
able 1
aseline characteristics of patients by depression screen status.
Negative depression screen, PHQ-2
score <2 (n = 485)
Study variables
Demographic characteristics
Gender, Male 313 (64.5) 
Age,  mean (SD) 66.39 (13.9) 
Married 318 (65.6) 
Lives  alone 110 (22.6) 
Employed 188 (38.7) 
Medical variables
DM 139 (28.6) 
Hyperchol. 289 (59.5) 
HTN  312 (55.6) 
Current smoker 51 (10.5) 
Prior  MI  96 (19.7) 
Prior  CVA 67 (13.8) 
CABG  81 (16.7) 
Hosp  6 months 132 (27.2) 
WBC  count, mean (SD) 8.48 (5.4) 
Admission diagnosis of MI  17 (15.7) 
Admission medications
Anxiolytic 37 (7.6) 
Beta-blocker 329 (67.8) 
Antidepressant 63 (12.9) 
ariables are reported as n (%) unless otherwise speciﬁed.
ABG, coronary artery bypass graft; CVA, cerebrovascular accident; DM,  diabetes mellitu
erolemia; HTN, hypertension; MI,  myocardial infarction; PHQ-2, Patient Health Questiondiology 60 (2012) 72–77
not include multivariate analysis via regression because of the small
sample size and thus overﬁtting.
Results
Overall, 561 patients were consecutively screened with the
PHQ-2. The primary diagnoses for these patients were UA (n = 198;
35.3%), arrhythmia (n = 133; 23.7%), MI  (n = 90; 16.0%), CHF (n = 71;
12.7%), closure of patient foramen ovale (n = 19; 3.4%), valvular
disease (n = 16; 2.9%), peripheral arterial disease (n = 7; 1.2%), and
other diagnoses (n = 27; 4.8%). The distribution of PHQ-2 scores in
the screened patients is displayed in Fig. 1; in total, 76 (13.5%) of
patients had a PHQ-2 score of 2 or greater and 47 (8.4%) had a PHQ-2
score of 3 or greater.
On univariate analysis (Table 1), variables associated with
a PHQ-2 score of 2 or greater were being unmarried (47.3%
with positive depression screen were married vs. 89.8% with
negative depression screen; 2 = 9.34; p = 0.002), living alone
(36.8% vs. 22.6%; 2 = 7.1; p = 0.008), current smoking (23.6% vs.
10.5%; 2 = 10.56; p = 0.001), having a higher mean WBC  count
(10.72 ± 9.8 × 109 cells per liter vs. 8.48 ± 5.4 × 109 cells per liter;
t = −2.88; p = 0.004), and prescription of antidepressant medication
(30.8% vs. 12.9%; 2 = 15.1; p < 0.001). There were no signiﬁcant
between-group differences in any of the other variables.
After controlling for confounding via multivariate logistic
regression analysis (Table 2), having a higher admission WBC
count [odds ratio (OR) = 2.19; 95% conﬁdence interval (CI):
1.25–3.83; p = 0.006] and prescription of antidepressant medica-
tions (OR = 2.36; 95% CI: 1.30–4.28; p = 0.005) were independently
associated with a positive depression screen using a cutoff of PHQ-
2 score of 2 or greater. Additionally, current smoking at admission
showed a trend toward signiﬁcance (OR = 1.86; 95% CI: 0.93–3.72;
p = 0.079).
Regarding exploratory analyses, when a cutoff score of PHQ-
2 ≥ 3 was used, variables associated with a positive depressiont = 3.08; p = 0.002), current smoking (25.5% with positive depression
screen were smokers vs. 11.1% with negative depression screen;
2 = 8.32; p = 0.004), not having been hospitalized in the past 6
Positive depression screen, PHQ-2
score ≥ 2 (n = 76)
p-Value
41 (53.9) 0.08
63.61 (13.3) 0.95
36 (47.3) 0.002
28 (36.8) 0.008
23 (30.2) 0.16
23 (30.2) 0.77
51 (67.1) 0.21
50 (65.7) 0.81
18 (23.6) 0.001
14 (18.4) 0.78
15 (19.7) 0.17
14 (18.4) 0.71
15 (19.7) 0.17
10.72 (9.8) 0.004
14 (18.4) 0.54
10 (13.1) 0.11
49 (64.4) 0.56
23 (30.2) <0.001
s; Hosp 6 months, hospitalized in the previous 6 months; Hyperchol, hypercholes-
naire-2; SD, standard deviation; WBC, white blood cell.
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Table  2
Logistic regression assessing variables associated with positive depression screens.
OR Z-score p-Value 95% Conﬁdence interval for OR
Gender 0.76 −1.03 0.30 0.44–1.29
Age 0.99  −1.26 0.21 0.97–1.01
Marriage 0.77 −0.69 0.49 0.37–1.61
Lives  alone 1.49 1.03 0.30 0.70–3.17
DM  1.13 0.41 0.69 0.64–1.98
MI  at admission 0.72 −0.92 0.36 0.35–1.46
Current smoker 1.86 1.76 0.079 0.93–3.73
Hosp  6 months 0.68 −1.17 0.24 0.36–1.29
WBC  count > 10 2.19 2.74 0.006 1.25–3.82
Anxiolytic 1.48 0.96 0.34 0.67–3.31
Beta-blocker 1.00 0.01 0.99 0.57–1.78
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M,  diabetes mellitus; Hosp 6 months, previous hospitalization within 6 months; M
onths (27.4% vs. 12.8%; 2 = 4.79; p = 0.029), prescription of an
nxiolytic medication (19.1% vs. 7.4%; 2 = 7.75; p = 0.005), and pre-
cription of antidepressant medication (29.8% vs. 14.0%; 2 = 8.26;
 = 0.004). WBC  count remained numerically greater in patients
ith positive depression screens (9.90 ± 5.6 ×109 cells per liter
s. 8.68 ± 6.3 × 109 cells per liter), but was no longer signiﬁcantly
ifferent (p = 0.21).
Operating characteristics of these predictor variables are out-
ined in Table 3. Overall, 26.1% (18/69) of smokers, 22.8% (28/123)
f patients with a WBC  count > 10.0 × 109 cells per liter, and 30.2%
26/86) of patients on antidepressants had a positive depression
creen. Furthermore, 35.8% (19/53) subjects with two  or more of
hese three factors had a positive depression screen.
Finally, for our subgroup analyses by diagnosis, for patients
ith UA, we found that being unmarried (2 = 5.66; p = 0.017),
iving alone (2 = 5.33; p = 0.021), smoking (2 = 6.83; p = 0.009),
aving a history of depression (2 = 23.76; p < 0.001), having a
istory of anxiety (2 = 7.82; p = 0.005), and antidepressant pre-
cription (2 = 5.54; p = 0.019) were signiﬁcantly associated with
aving a positive depression screen. For patients with arrhythmia,
e found that smoking (2 = 4.67; p = 0.031), history of anxi-
ty (2 = 14.32; p < 0.001), WBC  count > 10.0 × 109 cells per liter
2 = 11.33; p = 0.001), anxiolytic prescription (2 = 7.19; p = 0.007),
nd antidepressant prescription (2 = 4.20; p = 0.040) were associ-
ted with positive depression screens.
iscussion
In sum, in a sample of 561 patients admitted to inpatient cardiac
nits, we found that higher WBC  count at admission and pre-
cription of antidepressants were independently associated with
 positive PHQ-2 depression screen when using a cutoff score of 2
r greater. Smoking, although not statistically signiﬁcant, showed
 trend toward signiﬁcance.
Our ﬁndings were largely consistent with previous research inhis area. Our prevalence rate of positive depression screens (13.5%)
s higher than the prevalence rate of depression of 5% in the general
opulation [11] and similar to the prevalence rates of depression
able 3
perating characteristics for our depression screen predictors.
WBC  > 10 Antidepressant Smoking
Sensitivity 27/76 = 0.36 23/76 = 0.30 18/76 = 0.24
Speciﬁcity 394/485 = 0.81 422/486 = 0.87 434/485 = 0.89
PPV 27/118 = 0.23 23/86 = 0.27 18/69 = 0.26
NPV 394/443 = 0.89 422/475 = 0.89 434/492 = 0.88
OCC 421/561 = 0.75 445/561 = 0.79 452/561 = 0.81
PV, negative predictive value; OCC, overall correct classiﬁcation; PPV, positive
redictive value; WBC, white blood cell.0.005 1.30–4.28
ocardial infarction; OR, odds ratio; WBC, white blood cell.
found in other cardiac populations of 15–20% [2,5]; it is also similar
to the rate of positive depression screens (PHQ-2 ≥ 2) of 16.8% in a
large prospective study of cardiac outpatients [17].
The relation between elevated WBC  count and depression is
widely reported in the literature [23,27], including reports of such
an association in patients with cardiac disease [23]. Although the
reasons for such an elevation of WBC  in depressed patients is
unclear, one hypothesis is that depression, as an inﬂammatory
state [28], may  lead to elevation of WBC  values in serum and
to increased production of interleukins, leading to atherosclerosis
progression. However, there is conﬂicting evidence in the relation
between depression in cardiac patients and inﬂammatory mark-
ers, with some authors ﬁnding an association [22,29],  while others
ﬁndings a very small or no association [30,31].  In our sample, which
investigated only those parameters that were immediately avail-
able to front-line clinicians, we did not assess the impact of multiple
inﬂammatory markers, and even WBC  differential counts (e.g. to
assess neutrophil and lymphocyte counts) were not available in
the majority of patients.
Prescription of antidepressant medication at admission was also
independently associated with a positive depression screen. This
ﬁnding likely serves as a marker for those patients with recently or
previously diagnosed depressive disorders (or those with illnesses
frequently comorbid with depression and treated with antidepres-
sants, such as anxiety disorders). Given that the majority of patients
receiving antidepressants do not receive treatment with adequate
doses or duration, and that several trials of treatment are often
required before remission is reached [32], it is not surprising that
those patients who  have depression and are treated with antide-
pressants may  still have ongoing depressive symptoms; duration
of antidepressant use for each patient was not known. Of note,
we deliberately did not include a recorded history of depression
(or anxiety) as a potential risk factor. Our clinical and research
experience has been that a history of depression and anxiety are
rather inconsistently reported in cardiac patients’ past medical
history, and we instead chose to use antidepressant medication
prescription as a more objective potential marker of being at risk
for depression at admission.
Finally, smoking, although not a statistically signiﬁcant risk fac-
tor in multivariate analysis, did show a trend toward signiﬁcance.
This ﬁnding is consistent with previous ﬁndings over decades
[18,22,24]. The cause of this association is not yet fully understood;
some authors have proposed that nicotine use may  be a method
of self-medication to reduce anxiety and dysphoria in people with
depression [33]. More recent publications have suggested a step-
wise relationship between tobacco use and the subsequent onset of
depressive symptoms [34,35]; it is not clear whether smoking may
cause depressive symptoms or whether early smoking is a marker
of psychosocial distress or other factors that are linked to depres-
sion. Given the small number of current smokers in this cohort
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approximately 12%), one possible explanation for this lack of sig-
iﬁcance is that our study sample did not allow for adequate power
o detect a difference in depression screen rates between smok-
rs and nonsmokers. It is possible that a larger sample may  have
esulted in signiﬁcant between-group differences.
Regarding demographic variables, only living alone and unmar-
ied status were associated with positive depression screens on
nivariate analysis, and no demographic variables were associ-
ted with positive screens on multivariate analysis. Some prior
tudies in cardiac patients have found links between depression
nd younger age [20,36], female gender [23], and poor social sup-
ort/living alone [36]. The ﬁndings in our sample may  be due to the
act that our patients had a wide variety of cardiac diseases (prior
tudies evaluated patients with a single cardiac illness), that some
actors we analyzed were not included in the prior studies (e.g.
BC  count), and that our evaluations were performed at the time of
dmission (other studies have performed screens after discharge).
We chose to assess depression at admission. Although it may
e argued that depressive symptoms on hospital admission could
e a transient reaction to acute medical illness, we have found that
ardiac patients identiﬁed with the PHQ-2 on admission and found
o have clinical depression on further evaluation with the PHQ-9
id not have transient depression but instead often had chronic,
ecurrent, and moderately severe depression [37]. In addition, if
linically-signiﬁcant depression is identiﬁed in the hospital, the
npatient setting allows time for further evaluation, care coordi-
ation, and initiation of treatment in a monitored setting; indeed,
arly treatment initiation may  be important given that depression
ppears to be associated with increased rates of cardiac complica-
ions even in the short term [7,9].
This study had both strengths and limitations. One strength
f this investigation involves the wide range of cardiac patients
ncluded in the analyses; this is important given that screening
atients with only certain diagnoses may  be more logistically
omplicated in busy clinical settings, and depression is asso-
iated with negative outcomes in nearly every cardiovascular
ondition [7,8,10]. We  used variables that would typically be
vailable to front-line cardiac nurses and physicians without
equiring extra effort or specialized knowledge to obtain the
isk factor data, potentially increasing the feasibility of perform-
ng such screening. Furthermore, we evaluated the predictors
f a positive depression screen at the time of admission to
he hospital; prior studies of depression risk factors in car-
iac patients have focused on correlates of depression at the
ime of discharge or following hospitalization [4,38].  Depression
creening at admission ﬂows well as part of the overall intake
rocess, and we have found that such screening is well-accepted
y patients and staff and not substantially resource-intensive
13].
Limitations include the fact that this study was performed in a
ingle academic medical center, with a largely Caucasian popula-
ion. We  could not analyze all possible risk factors for depression
n the logistic regression model to avoid overﬁtting, and even our
urrent analysis must be considered somewhat exploratory despite
ur relatively large sample of over 500 consecutively-screened
atients. We  also did not have adequate information to analyze
dditional variables of interest, including WBC  differential, body
ass index, CHF class, or duration of medical symptoms. Given the
ocus of this study on ‘real-world’ depression screening and risk
actor availability, depression screening and listing of risk factors
n admission notes was performed by clinicians as part of usual
are without monitoring or interference from study staff. Finally,
his study only investigated positive depression screens and not
atients with a formal depression diagnosis, although prior work
as found high rates of correlation between PHQ-2 depression
creens and major depression [16]. Furthermore, a recent study
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found that positive PHQ-2 screens independently predicted 12
month mortality in CHF patients [39].
In conclusion, in a sample of 561 consecutively screened car-
diac inpatients, we found that increased WBC  count at admission
and the use of antidepressants were independently associated
with a positive PHQ-2 depression screen, while smoking showed
a trend toward signiﬁcance. There is currently substantial con-
troversy regarding the routine screening of cardiac patients for
depression [14], and some settings may  choose to focus limited
resources by screening a subgroup of the population at a higher
risk for depression. If so, a program that screens those with WBC
counts >10.0 × 109 cells per liter, those taking antidepressants,
and perhaps current smokers, should yield higher rates of positive
depression screens.
Although the predictive value of these three variables is to some
degree limited, using the presence or absence of our three vari-
ables as a prompt for screening would approximately double the
positive screening rate for patients while avoiding screening in
the majority of patients. Thus this information may  have clini-
cal utility in certain settings by substantially reducing provider
time and energy. In addition, even if this information does not
have direct clinical utility, understanding more about risk fac-
tors for depression/depression screens in cardiac patients may  still
be of importance, given the substantial and independent links
between depression and morbidity/mortality in this population.
For example, this work could add to the literature on smoking and
depression in cardiac patients, both of which have been indepen-
dently linked with mortality, and may  prompt further examination
of interconnections between stress response/margination, depres-
sion, inﬂammation, and cardiac outcomes, given the link between
WBC  count and positive depression screens in our analysis.
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